| PD-L1 immunohistochemistry comparability study in real-life clinical samples: results of blueprint phase 2 project MS Tsao, KM Kerr, M Kockx, MB Beasley, AC Borczuk, J Botling, ... Journal of Thoracic Oncology 13 (9), 1302-1311, 2018 | 709 | 2018 |
| Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary … ME Caplin, E Baudin, P Ferolla, P Filosso, M Garcia-Yuste, E Lim, ... Annals of Oncology 26 (8), 1604-1620, 2015 | 668 | 2015 |
| Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial U Pastorino, M Rossi, V Rosato, A Marchiano, N Sverzellati, C Morosi, ... European Journal of Cancer Prevention 21 (3), 308-315, 2012 | 520 | 2012 |
| Alterations of the Notch pathway in lung cancer B Westhoff, IN Colaluca, G D'Ario, M Donzelli, D Tosoni, S Volorio, ... Proceedings of the National Academy of Sciences 106 (52), 22293-22298, 2009 | 496 | 2009 |
| A serum circulating miRNA diagnostic test to identify asymptomatic high‐risk individuals with early stage lung cancer F Bianchi, F Nicassio, M Marzi, E Belloni, V Dall'Olio, L Bernard, G Pelosi, ... EMBO molecular medicine 3 (8), 495-503, 2011 | 422 | 2011 |
| Clinical response of carcinomas harboring the BRD4–NUT oncoprotein to the targeted bromodomain inhibitor OTX015/MK-8628 A Stathis, E Zucca, M Bekradda, C Gomez-Roca, JP Delord, ... Cancer discovery 6 (5), 492-500, 2016 | 386 | 2016 |
| A grading system for invasive pulmonary adenocarcinoma: a proposal from the International Association for the Study of Lung Cancer Pathology Committee AL Moreira, PSS Ocampo, Y Xia, H Zhong, PA Russell, Y Minami, ... Journal of Thoracic Oncology 15 (10), 1599-1610, 2020 | 334 | 2020 |
| Endocrine tumors of the pancreas: Ki-67 immunoreactivity on paraffin sections is an independent predictor for malignancy: a comparative study with proliferating-cell nuclear … G Pelosi, E Bresaola, G Bogina, F Pasini, S Rodella, P Castelli, C Iacono, ... Human pathology 27 (11), 1124-1134, 1996 | 317 | 1996 |
| Best practices recommendations for diagnostic immunohistochemistry in lung cancer Y Yatabe, S Dacic, AC Borczuk, A Warth, PA Russell, S Lantuejoul, ... Journal of thoracic oncology 14 (3), 377-407, 2019 | 315 | 2019 |
| IASLC multidisciplinary recommendations for pathologic assessment of lung cancer resection specimens after neoadjuvant therapy WD Travis, S Dacic, I Wistuba, L Sholl, P Adusumilli, L Bubendorf, P Bunn, ... Journal of Thoracic Oncology 15 (5), 709-740, 2020 | 299 | 2020 |
| Typical and atypical pulmonary carcinoid tumor overdiagnosed as small-cell carcinoma on biopsy specimens: a major pitfall in the management of lung cancer patients G Pelosi, J Rodriguez, G Viale, J Rosai The American journal of surgical pathology 29 (2), 179-187, 2005 | 293 | 2005 |
| PD-L1 testing for lung cancer in 2019: perspective from the IASLC pathology committee S Lantuejoul, M Sound-Tsao, WA Cooper, N Girard, FR Hirsch, AC Roden, ... Journal of Thoracic Oncology 15 (4), 499-519, 2020 | 262 | 2020 |
| TNM staging system of colorectal carcinoma: a critical appraisal of challenging issues G Puppa, A Sonzogni, R Colombari, G Pelosi Archives of pathology & laboratory medicine 134 (6), 837-852, 2010 | 253 | 2010 |
| Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma. An international interobserver study E Thunnissen, MB Beasley, AC Borczuk, E Brambilla, LR Chirieac, ... Modern pathology 25 (12), 1574-1583, 2012 | 250 | 2012 |
| WHO panel WD Travis, E Brambilla, AG Nicholson, Y Yatabe, JHM Austin, ... The, 2015 | 243 | 2015 |
| Grading the neuroendocrine tumors of the lung: an evidence-based proposal G Rindi, C Klersy, F Inzani, G Fellegara, L Ampollini, A Ardizzoni, ... Endocr Relat Cancer 21 (1), 1-16, 2014 | 241 | 2014 |
| A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers A Decensi, C Robertson, G Viale, F Pigatto, H Johansson, ER Kisanga, ... Journal of the National Cancer Institute 95 (11), 779-790, 2003 | 235 | 2003 |
| Tamoxifen and metabolite concentrations in serum and breast cancer tissue during three dose regimens in a randomized preoperative trial ER Kisanga, J Gjerde, A Guerrieri-Gonzaga, F Pigatto, A Pesci-Feltri, ... Clinical Cancer Research 10 (7), 2336-2343, 2004 | 234 | 2004 |
| Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer G Pelosi, U Pastorino, F Pasini, P Maissoneuve, F Fraggetta, A Sonzogni, ... British journal of cancer 88 (4), 537-547, 2003 | 234 | 2003 |
| Pulmonary sarcomatoid carcinomas: a practical overview G Pelosi, A Sonzogni, T De Pas, D Galetta, G Veronesi, L Spaggiari, ... International journal of surgical pathology 18 (2), 103-120, 2010 | 231 | 2010 |
